APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Fourth Generation Fluoroquinolones

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Fourth Generation Fluoroquinolones Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173993090326 December 2025184 pages

Choose your research edition.

Industry ResearchFourth Generation Fluoroquinolones Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Fourth Generation Fluoroquinolones Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Fourth Generation Fluoroquinolones Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fourth Generation Fluoroquinolones Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Fourth Generation Fluoroquinolones Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Fourth Generation Fluoroquinolones market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Fourth Generation Fluoroquinolones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fourth Generation Fluoroquinolones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fourth Generation Fluoroquinolones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Fourth Generation Fluoroquinolones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fourth Generation Fluoroquinolones include Takeda, Sanofi, Nanjing Youke Pharmaceutical, Pfizer, Daiichi Sankyo Co., Ltd., Otsuka Holdings, Bayer AG and Astellas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fourth Generation Fluoroquinolones market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fourth Generation Fluoroquinolones and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fourth Generation Fluoroquinolones sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fourth Generation Fluoroquinolones market size, projected growth trends, production technologies, key applications, and end-use industries.

Fourth Generation Fluoroquinolones Segment by Company

Takeda

Sanofi

Nanjing Youke Pharmaceutical

Pfizer

Daiichi Sankyo Co., Ltd.

Otsuka Holdings

Bayer AG

Astellas

Fourth Generation Fluoroquinolones Segment by Type

Besifloxacin

Delafloxacin

Jimmyfloxacin

Gatifloxacin

Moxifloxacin

Prulifloxacin

Sitafloxacin

Others

Fourth Generation Fluoroquinolones Segment by Application

Skin And Soft Tissue Infections

Urinary Tract Disease

Respiratory Diseases

Bone, Joint, And Soft Tissue Infections

Intestinal Infections And Typhoid Fever

Others

Fourth Generation Fluoroquinolones Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fourth Generation Fluoroquinolones market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fourth Generation Fluoroquinolones and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fourth Generation Fluoroquinolones.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fourth Generation Fluoroquinolones market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fourth Generation Fluoroquinolones manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Fourth Generation Fluoroquinolones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Fourth Generation Fluoroquinolones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Fourth Generation Fluoroquinolones Industry Trends Table 2. Fourth Generation Fluoroquinolones Industry Drivers Table 3. Fourth Generation Fluoroquinolones Industry Opportunities and Challenges Table 4. Fourth Generation Fluoroquinolones Industry Restraints Table 5. Global Fourth Generation Fluoroquinolones Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Fourth Generation Fluoroquinolones Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Fourth Generation Fluoroquinolones Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Fourth Generation Fluoroquinolones Sales Market Share by Manufacturers Table 9. Global Fourth Generation Fluoroquinolones Average Sales Price (US$/K Unit) of Manufacturers (2021-2026) Table 10. Global Fourth Generation Fluoroquinolones Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Fourth Generation Fluoroquinolones Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Fourth Generation Fluoroquinolones Manufacturers, Product Type & Application Table 13. Global Fourth Generation Fluoroquinolones Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Fourth Generation Fluoroquinolones by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Besifloxacin Table 17. Major Manufacturers of Delafloxacin Table 18. Major Manufacturers of Jimmyfloxacin Table 19. Major Manufacturers of Gatifloxacin Table 20. Major Manufacturers of Moxifloxacin Table 21. Major Manufacturers of Prulifloxacin Table 22. Major Manufacturers of Sitafloxacin Table 23. Major Manufacturers of Others Table 24. Global Fourth Generation Fluoroquinolones Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (K Units) Table 26. Global Fourth Generation Fluoroquinolones Sales by Type (2027-2032) & (K Units) Table 27. Global Fourth Generation Fluoroquinolones Sales Market Share by Type (2021-2026) Table 28. Global Fourth Generation Fluoroquinolones Sales Market Share by Type (2027-2032) Table 29. Global Fourth Generation Fluoroquinolones Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 30. Global Fourth Generation Fluoroquinolones Revenue by Type (2021-2026) & (K Units) Table 31. Global Fourth Generation Fluoroquinolones Revenue by Type (2027-2032) & (K Units) Table 32. Global Fourth Generation Fluoroquinolones Revenue Market Share by Type (2021-2026) Table 33. Global Fourth Generation Fluoroquinolones Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of Skin And Soft Tissue Infections Table 35. Major Manufacturers of Urinary Tract Disease Table 36. Major Manufacturers of Respiratory Diseases Table 37. Major Manufacturers of Bone, Joint, And Soft Tissue Infections Table 38. Major Manufacturers of Intestinal Infections And Typhoid Fever Table 39. Major Manufacturers of Others Table 40. Global Fourth Generation Fluoroquinolones Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (K Units) Table 42. Global Fourth Generation Fluoroquinolones Sales by Application (2027-2032) & (K Units) Table 43. Global Fourth Generation Fluoroquinolones Sales Market Share by Application (2021-2026) Table 44. Global Fourth Generation Fluoroquinolones Sales Market Share by Application (2027-2032) Table 45. Global Fourth Generation Fluoroquinolones Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 46. Global Fourth Generation Fluoroquinolones Revenue by Application (2021-2026) & (K Units) Table 47. Global Fourth Generation Fluoroquinolones Revenue by Application (2027-2032) & (K Units) Table 48. Global Fourth Generation Fluoroquinolones Revenue Market Share by Application (2021-2026) Table 49. Global Fourth Generation Fluoroquinolones Revenue Market Share by Application (2027-2032) Table 50. Global Fourth Generation Fluoroquinolones Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 51. Global Fourth Generation Fluoroquinolones Sales by Region (2021-2026) & (K Units) Table 52. Global Fourth Generation Fluoroquinolones Sales Market Share by Region (2021-2026) Table 53. Global Fourth Generation Fluoroquinolones Sales Forecasted by Region (2027-2032) & (K Units) Table 54. Global Fourth Generation Fluoroquinolones Sales Forecasted Market Share by Region (2027-2032) Table 55. North America Fourth Generation Fluoroquinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. North America Fourth Generation Fluoroquinolones Sales by Country (2021-2026) & (K Units) Table 57. North America Fourth Generation Fluoroquinolones Sales by Country (2027-2032) & (K Units) Table 58. Europe Fourth Generation Fluoroquinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Europe Fourth Generation Fluoroquinolones Sales by Country (2021-2026) & (K Units) Table 60. Europe Fourth Generation Fluoroquinolones Sales by Country (2027-2032) & (K Units) Table 61. Asia Pacific Fourth Generation Fluoroquinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. Asia Pacific Fourth Generation Fluoroquinolones Sales by Country (2021-2026) & (K Units) Table 63. Asia Pacific Fourth Generation Fluoroquinolones Sales by Country (2027-2032) & (K Units) Table 64. South America, Middle East and Africa Fourth Generation Fluoroquinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 65. South America, Middle East and Africa Fourth Generation Fluoroquinolones Sales by Country (2021-2026) & (K Units) Table 66. South America, Middle East and Africa Fourth Generation Fluoroquinolones Sales by Country (2027-2032) & (K Units) Table 67. Global Fourth Generation Fluoroquinolones Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Global Fourth Generation Fluoroquinolones Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Fourth Generation Fluoroquinolones Revenue by Region (2027-2032) & (US$ Million) Table 70. Global Fourth Generation Fluoroquinolones Revenue Market Share by Region (2021-2026) Table 71. Global Fourth Generation Fluoroquinolones Revenue Market Share by Region (2027-2032) Table 72. Takeda Company Information Table 73. Takeda Business Overview Table 74. Takeda Fourth Generation Fluoroquinolones Sales (K Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Takeda Fourth Generation Fluoroquinolones Product Portfolio Table 76. Takeda Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Fourth Generation Fluoroquinolones Sales (K Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Sanofi Fourth Generation Fluoroquinolones Product Portfolio Table 81. Sanofi Recent Development Table 82. Nanjing Youke Pharmaceutical Company Information Table 83. Nanjing Youke Pharmaceutical Business Overview Table 84. Nanjing Youke Pharmaceutical Fourth Generation Fluoroquinolones Sales (K Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Nanjing Youke Pharmaceutical Fourth Generation Fluoroquinolones Product Portfolio Table 86. Nanjing Youke Pharmaceutical Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Fourth Generation Fluoroquinolones Sales (K Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Pfizer Fourth Generation Fluoroquinolones Product Portfolio Table 91. Pfizer Recent Development Table 92. Daiichi Sankyo Co., Ltd. Company Information Table 93. Daiichi Sankyo Co., Ltd. Business Overview Table 94. Daiichi Sankyo Co., Ltd. Fourth Generation Fluoroquinolones Sales (K Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Daiichi Sankyo Co., Ltd. Fourth Generation Fluoroquinolones Product Portfolio Table 96. Daiichi Sankyo Co., Ltd. Recent Development Table 97. Otsuka Holdings Company Information Table 98. Otsuka Holdings Business Overview Table 99. Otsuka Holdings Fourth Generation Fluoroquinolones Sales (K Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Otsuka Holdings Fourth Generation Fluoroquinolones Product Portfolio Table 101. Otsuka Holdings Recent Development Table 102. Bayer AG Company Information Table 103. Bayer AG Business Overview Table 104. Bayer AG Fourth Generation Fluoroquinolones Sales (K Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Bayer AG Fourth Generation Fluoroquinolones Product Portfolio Table 106. Bayer AG Recent Development Table 107. Astellas Company Information Table 108. Astellas Business Overview Table 109. Astellas Fourth Generation Fluoroquinolones Sales (K Units), Price (US$/K Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Astellas Fourth Generation Fluoroquinolones Product Portfolio Table 111. Astellas Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Fourth Generation Fluoroquinolones Distributors List Table 115. Fourth Generation Fluoroquinolones Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Fourth Generation Fluoroquinolones Product Image Figure 2. Global Fourth Generation Fluoroquinolones Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fourth Generation Fluoroquinolones Market Size (2021-2032) & (US$ Million) Figure 4. Global Fourth Generation Fluoroquinolones Sales (2021-2032) & (K Units) Figure 5. Global Fourth Generation Fluoroquinolones Average Price (US$/K Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Fourth Generation Fluoroquinolones Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Besifloxacin Image Figure 9. Delafloxacin Image Figure 10. Jimmyfloxacin Image Figure 11. Gatifloxacin Image Figure 12. Moxifloxacin Image Figure 13. Prulifloxacin Image Figure 14. Sitafloxacin Image Figure 15. Others Image Figure 16. Global Fourth Generation Fluoroquinolones Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Fourth Generation Fluoroquinolones Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global Fourth Generation Fluoroquinolones Sales Market Share by Type (2021-2032) Figure 19. Global Fourth Generation Fluoroquinolones Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Fourth Generation Fluoroquinolones Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Fourth Generation Fluoroquinolones Revenue Market Share by Type (2021-2032) Figure 22. Skin And Soft Tissue Infections Image Figure 23. Urinary Tract Disease Image Figure 24. Respiratory Diseases Image Figure 25. Bone, Joint, And Soft Tissue Infections Image Figure 26. Intestinal Infections And Typhoid Fever Image Figure 27. Others Image Figure 28. Global Fourth Generation Fluoroquinolones Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 29. Global Fourth Generation Fluoroquinolones Sales Market Share 2021 VS 2025 VS 2032 Figure 30. Global Fourth Generation Fluoroquinolones Sales Market Share by Application (2021-2032) Figure 31. Global Fourth Generation Fluoroquinolones Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Fourth Generation Fluoroquinolones Revenue Market Share 2021 VS 2025 VS 2032 Figure 33. Global Fourth Generation Fluoroquinolones Revenue Market Share by Application (2021-2032) Figure 34. North America Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 35. North America Fourth Generation Fluoroquinolones Sales Market Share by Country (2021-2032) Figure 36. U.S. Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Canada Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Mexico Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Europe Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Europe Fourth Generation Fluoroquinolones Sales Market Share by Country (2021-2032) Figure 41. Germany Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 42. France Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 43. U.K. Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Italy Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Netherlands Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Asia Pacific Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Asia Pacific Fourth Generation Fluoroquinolones Sales Market Share by Country (2021-2032) Figure 48. China Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Japan Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Korea Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Southeast Asia Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 52. India Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Australia Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 54. South America, Middle East and Africa Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 55. South America, Middle East and Africa Fourth Generation Fluoroquinolones Sales Market Share by Country (2021-2032) Figure 56. Brazil Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 57. South Africa Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Saudi Arabia Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Turkey Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Argentina Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 61. UAE Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Egypt Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 63. Chile Fourth Generation Fluoroquinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 64. Global Fourth Generation Fluoroquinolones Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 65. Global Fourth Generation Fluoroquinolones Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 66. North America Fourth Generation Fluoroquinolones Revenue (2021-2032) & (US$ Million) Figure 67. North America Fourth Generation Fluoroquinolones Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Europe Fourth Generation Fluoroquinolones Revenue (2021-2032) & (US$ Million) Figure 69. Europe Fourth Generation Fluoroquinolones Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Asia-Pacific Fourth Generation Fluoroquinolones Revenue (2021-2032) & (US$ Million) Figure 71. Asia-Pacific Fourth Generation Fluoroquinolones Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. South America, Middle East and Africa Fourth Generation Fluoroquinolones Revenue (2021-2032) & (US$ Million) Figure 73. South America, Middle East and Africa Fourth Generation Fluoroquinolones Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 74. Fourth Generation Fluoroquinolones Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Fourth Generation Fluoroquinolones Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Besifloxacin
  • Delafloxacin
  • Jimmyfloxacin
  • Gatifloxacin
  • Moxifloxacin
  • Prulifloxacin
  • Sitafloxacin
  • Others
Applications
  • Skin And Soft Tissue Infections
  • Urinary Tract Disease
  • Respiratory Diseases
  • Bone, Joint, And Soft Tissue Infections
  • Intestinal Infections And Typhoid Fever
  • Others
Companies covered
  • Takeda
  • Sanofi
  • Nanjing Youke Pharmaceutical
  • Pfizer
  • Daiichi Sankyo Co., Ltd.
  • Otsuka Holdings
  • Bayer AG
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fourth Generation Fluoroquinolones Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fourth Generation Fluoroquinolones Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Fourth Generation Fluoroquinolones Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Fourth Generation Fluoroquinolones Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Fourth Generation Fluoroquinolones Market Dynamics
  1. 2.1 Fourth Generation Fluoroquinolones Industry Trends
  2. 2.2 Fourth Generation Fluoroquinolones Industry Drivers
  3. 2.3 Fourth Generation Fluoroquinolones Industry Opportunities and Challenges
  4. 2.4 Fourth Generation Fluoroquinolones Industry Restraints
3 Fourth Generation Fluoroquinolones Market by Manufacturers
  1. 3.1 Global Fourth Generation Fluoroquinolones Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Fourth Generation Fluoroquinolones Sales by Manufacturers (2021-2026)
  3. 3.3 Global Fourth Generation Fluoroquinolones Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Fourth Generation Fluoroquinolones Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fourth Generation Fluoroquinolones Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Fourth Generation Fluoroquinolones Manufacturers, Product Type & Application
  7. 3.7 Global Fourth Generation Fluoroquinolones Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fourth Generation Fluoroquinolones Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fourth Generation Fluoroquinolones Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fourth Generation Fluoroquinolones Tier 1, Tier 2, and Tier 3
4 Fourth Generation Fluoroquinolones Market by Type
  1. 4.1 Fourth Generation Fluoroquinolones Type Introduction
  2. 4.1.1 Besifloxacin
  3. 4.1.2 Delafloxacin
  4. 4.1.3 Jimmyfloxacin
  5. 4.1.4 Gatifloxacin
  6. 4.1.5 Moxifloxacin
  7. 4.1.6 Prulifloxacin
  8. 4.1.7 Sitafloxacin
  9. 4.1.8 Others
  10. 4.2 Global Fourth Generation Fluoroquinolones Sales by Type
  11. 4.2.1 Global Fourth Generation Fluoroquinolones Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Fourth Generation Fluoroquinolones Sales by Type (2021-2032)
  13. 4.2.3 Global Fourth Generation Fluoroquinolones Sales Market Share by Type (2021-2032)
  14. 4.3 Global Fourth Generation Fluoroquinolones Revenue by Type
  15. 4.3.1 Global Fourth Generation Fluoroquinolones Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Fourth Generation Fluoroquinolones Revenue by Type (2021-2032)
  17. 4.3.3 Global Fourth Generation Fluoroquinolones Revenue Market Share by Type (2021-2032)
5 Fourth Generation Fluoroquinolones Market by Application
  1. 5.1 Fourth Generation Fluoroquinolones Application Introduction
  2. 5.1.1 Skin And Soft Tissue Infections
  3. 5.1.2 Urinary Tract Disease
  4. 5.1.3 Respiratory Diseases
  5. 5.1.4 Bone, Joint, And Soft Tissue Infections
  6. 5.1.5 Intestinal Infections And Typhoid Fever
  7. 5.1.6 Others
  8. 5.2 Global Fourth Generation Fluoroquinolones Sales by Application
  9. 5.2.1 Global Fourth Generation Fluoroquinolones Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Fourth Generation Fluoroquinolones Sales by Application (2021-2032)
  11. 5.2.3 Global Fourth Generation Fluoroquinolones Sales Market Share by Application (2021-2032)
  12. 5.3 Global Fourth Generation Fluoroquinolones Revenue by Application
  13. 5.3.1 Global Fourth Generation Fluoroquinolones Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Fourth Generation Fluoroquinolones Revenue by Application (2021-2032)
  15. 5.3.3 Global Fourth Generation Fluoroquinolones Revenue Market Share by Application (2021-2032)
6 Global Fourth Generation Fluoroquinolones Sales by Region
  1. 6.1 Global Fourth Generation Fluoroquinolones Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fourth Generation Fluoroquinolones Sales by Region (2021-2032)
  3. 6.2.1 Global Fourth Generation Fluoroquinolones Sales by Region (2021-2026)
  4. 6.2.2 Global Fourth Generation Fluoroquinolones Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fourth Generation Fluoroquinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Fourth Generation Fluoroquinolones Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Fourth Generation Fluoroquinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Fourth Generation Fluoroquinolones Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Fourth Generation Fluoroquinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Fourth Generation Fluoroquinolones Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Fourth Generation Fluoroquinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Fourth Generation Fluoroquinolones Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Fourth Generation Fluoroquinolones Revenue by Region
  1. 7.1 Global Fourth Generation Fluoroquinolones Revenue by Region
  2. 7.1.1 Global Fourth Generation Fluoroquinolones Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Fourth Generation Fluoroquinolones Revenue by Region (2021-2026)
  4. 7.1.3 Global Fourth Generation Fluoroquinolones Revenue by Region (2027-2032)
  5. 7.1.4 Global Fourth Generation Fluoroquinolones Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Fourth Generation Fluoroquinolones Revenue (2021-2032)
  8. 7.2.2 North America Fourth Generation Fluoroquinolones Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Fourth Generation Fluoroquinolones Revenue (2021-2032)
  11. 7.3.2 Europe Fourth Generation Fluoroquinolones Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Fourth Generation Fluoroquinolones Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Fourth Generation Fluoroquinolones Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Fourth Generation Fluoroquinolones Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Fourth Generation Fluoroquinolones Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Fourth Generation Fluoroquinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Fourth Generation Fluoroquinolones Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Fourth Generation Fluoroquinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Fourth Generation Fluoroquinolones Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Nanjing Youke Pharmaceutical
  14. 8.3.1 Nanjing Youke Pharmaceutical Company Information
  15. 8.3.2 Nanjing Youke Pharmaceutical Business Overview
  16. 8.3.3 Nanjing Youke Pharmaceutical Fourth Generation Fluoroquinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nanjing Youke Pharmaceutical Fourth Generation Fluoroquinolones Product Portfolio
  18. 8.3.5 Nanjing Youke Pharmaceutical Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Fourth Generation Fluoroquinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Fourth Generation Fluoroquinolones Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Daiichi Sankyo Co., Ltd.
  26. 8.5.1 Daiichi Sankyo Co., Ltd. Company Information
  27. 8.5.2 Daiichi Sankyo Co., Ltd. Business Overview
  28. 8.5.3 Daiichi Sankyo Co., Ltd. Fourth Generation Fluoroquinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Daiichi Sankyo Co., Ltd. Fourth Generation Fluoroquinolones Product Portfolio
  30. 8.5.5 Daiichi Sankyo Co., Ltd. Recent Developments
  31. 8.6 Otsuka Holdings
  32. 8.6.1 Otsuka Holdings Company Information
  33. 8.6.2 Otsuka Holdings Business Overview
  34. 8.6.3 Otsuka Holdings Fourth Generation Fluoroquinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Otsuka Holdings Fourth Generation Fluoroquinolones Product Portfolio
  36. 8.6.5 Otsuka Holdings Recent Developments
  37. 8.7 Bayer AG
  38. 8.7.1 Bayer AG Company Information
  39. 8.7.2 Bayer AG Business Overview
  40. 8.7.3 Bayer AG Fourth Generation Fluoroquinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer AG Fourth Generation Fluoroquinolones Product Portfolio
  42. 8.7.5 Bayer AG Recent Developments
  43. 8.8 Astellas
  44. 8.8.1 Astellas Company Information
  45. 8.8.2 Astellas Business Overview
  46. 8.8.3 Astellas Fourth Generation Fluoroquinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Astellas Fourth Generation Fluoroquinolones Product Portfolio
  48. 8.8.5 Astellas Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fourth Generation Fluoroquinolones Value Chain Analysis
  2. 9.1.1 Fourth Generation Fluoroquinolones Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fourth Generation Fluoroquinolones Production Mode & Process
  6. 9.2 Fourth Generation Fluoroquinolones Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fourth Generation Fluoroquinolones Distributors
  9. 9.2.3 Fourth Generation Fluoroquinolones Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst